Comparison of evaluations of hormone receptors in breast carcinoma by image-analysis using three automated immunohistochemical stainings

Arihiro,Koji; Oda,Miyo; Ogawa,Katsunari; Tominaga,Kenshi; Kaneko,Yoshie; Shimizu,Tomomi; Ohnishi,Shiho; Oda,Megumi; Kurita,Yuki; Taira,Yuko; Fujii,Masayoshi; Tanaka,Maiko

doi:10.3892/etm.2010.142

Comparison of evaluations of hormone receptors in breast carcinoma by image-analysis using three automated immunohistochemical stainings

Authors:
- Koji Arihiro
- Miyo Oda
- Katsunari Ogawa
- Kenshi Tominaga
- Yoshie Kaneko
- Tomomi Shimizu
- Shiho Ohnishi
- Megumi Oda
- Yuki Kurita
- Yuko Taira
- Masayoshi Fujii
- Maiko Tanaka
View Affiliations

Affiliations: Department of Anatomical Pathology, Hiroshima University Hospital, Hiroshima 734-8551, Japan
Published online on: August 26, 2010 https://doi.org/10.3892/etm.2010.142
Pages: 927-932

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to compare the results of immunohistochemistry (IHC) assays evaluated by human examiners with the results evaluated by computerized image analysis, and to compare the computerized image analysis results among three automated IHC assays, namely the BioGenex, Dako and Ventana assays. All slides were semiquantitatively evaluated according to the Allred score and J-score by human examiners. The images were analyzed using MacSCOPE version 2.6 for Macintosh according to the H-score and the percentage of positive-stained nuclei per area of carcinoma cells (PP) irrespective of the intensity of the stained nuclei. The H-score for the estrogen receptor (ER) was significantly correlated with the Allred score (P<0.0001) and the PP for the ER was significantly correlated with the J-score (P<0.0001), suggesting that the image analysis used in the present study is a useful method for the evaluation of ER status. Several discrepancies were identified between the Allred score and H-score and between the PP and J-score due to the positive-stained cytoplasm area of carcinoma cells and/or the positive-stained nuclei area of non-carcinoma cells, including benign epithelial cells, lymphocytes and stromal cells. Accordingly, advances in the algorithm of the digitized analyzing system is necessary.

View Figures

View References

1.	Goldhirsch A, Ingle JN, Gelber RD, Coates AS, Thurlimann B and Senn HJ: Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol. 20:1319–1329. 2009. View Article : Google Scholar : PubMed/NCBI
2.	Arihiro K, Umemura S, Kurosumi M, et al: Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays. Am J Clin Pathol. 127:356–365. 2007. View Article : Google Scholar
3.	Oda M, Arihiro K, Kataoka T, Osaki A, Asahara T and Ohdan H: Comparison of immunohistochemical assays and reverse transcription real-time polymerase chain reaction for analyzing status of hormone receptors in human breast carcinoma. Pathol Int. 60:305–315. 2010. View Article : Google Scholar
4.	Bacus S, Flowers JL, Press MF, Bacus JW and McCarty KS Jr: The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol. 90:233–239. 1988.PubMed/NCBI
5.	Rostagno P, Birtwisle I, Ettore F, et al: Immunohistochemical determination of nuclear antigens by colour image analysis: application for labelling index, estrogen and progesterone receptor status in breast cancer. Anal Cell Pathol. 7:275–287. 1994.
6.	Layfield LJ, Saria EA, Conlon DH and Kerns BJ: Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: prognostic significance. J Surg Oncol. 61:177–184. 1996. View Article : Google Scholar
7.	Cohen C: Image cytometric analysis in pathology. Hum Pathol. 27:482–493. 1996. View Article : Google Scholar
8.	Lehr HA, Mankoff DA, Corwin D, Santeusanio G and Gown AM: Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem. 45:1559–1565. 1997. View Article : Google Scholar : PubMed/NCBI
9.	Bejar J, Sabo E, Misselevich I, Eldar S and Boss JH: Comparative study of computer-assisted image analysis and light-microscopically determined estrogen receptor status of breast carcinomas. Arch Pathol Lab Med. 122:346–352. 1998.
10.	Mofidi R, Walsh R, Ridgway PF, et al: Objective measurement of breast cancer oestrogen receptor status through digital image analysis. Eur J Surg Oncol. 29:20–24. 2003. View Article : Google Scholar : PubMed/NCBI
11.	Rothmann C, Barshack I, Gil A, Goldberg I, Kopolovic J and Malik Z: Potential use of spectral image analysis for the quantitative evaluation of estrogen receptors in breast cancer. Histol Histopathol. 15:1051–1057. 2000.PubMed/NCBI
12.	Vesoulis Z, Rajappannair L, Define L, Beach J, Schnell B and Myers S: Quantitative image analysis of estrogen receptors in breast fine needle aspiration biopsies. Anal Quant Cytol Histol. 26:323–330. 2004.PubMed/NCBI
13.	Fisher ER, Anderson S, Dean S, et al: Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma. Cancer. 103:164–173. 2005. View Article : Google Scholar : PubMed/NCBI
14.	Gokhale S, Rosen D, Sneige N, et al: Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol. 15:451–455. 2007. View Article : Google Scholar : PubMed/NCBI
15.	Hatanaka Y, Hashizume K, Nitta K, Kato T, Itoh I and Tani Y: Cytometrical image analysis for immunohistochemical hormone receptor status in breast carcinomas. Pathol Int. 53:693–699. 2003. View Article : Google Scholar : PubMed/NCBI
16.	Diaz LK, Sahin A and Sneige N: Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: a comparison of manual and computer-assisted scoring methods. Ann Diagn Pathol. 8:23–27. 2004. View Article : Google Scholar
17.	Sharangpani GM, Joshi AS, Porter K, et al: Semi-automated imaging system to quantitate estrogen and progesterone receptor immunoreactivity in human breast cancer. J Microsc. 226:244–255. 2007. View Article : Google Scholar : PubMed/NCBI
18.	Chung GG, Zerkowski MP, Ghosh S, Camp RL and Rimm DL: Quantitative analysis of estrogen receptor heterogeneity in breast cancer. Lab Invest. 87:662–669. 2007. View Article : Google Scholar : PubMed/NCBI
19.	Turbin DA, Leung S, Cheang MC, et al: Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat. 110:417–426. 2008. View Article : Google Scholar
20.	Rexhepaj E, Brennan DJ, Holloway P, et al: Novel image analysis approach for quantifying expression of nuclear proteins assessed by immunohistochemistry: application to measurement of oestrogen and progesterone receptor levels in breast cancer. Breast Cancer Res. 10:R892008. View Article : Google Scholar
21.	Allred DC, Harvey JM, Berardo M and Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 11:155–168. 1998.PubMed/NCBI
22.	Umemura S, Kurosumi M, Moriya T, et al: Immunohistochemical evaluation for hormone receptors in breast cancer: a practically useful evaluation system and handling protocol. Breast Cancer. 13:232–235. 2006. View Article : Google Scholar : PubMed/NCBI
23.	Goldhirsch A, Glick JH, Gelber RD, Coates AS, Thurlimann B and Senn HJ: Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. Ann Oncol. 16:1569–1583. 2005. View Article : Google Scholar : PubMed/NCBI
24.	Kaplan PA, Frazier SR, Loy TS, Diaz-Arias AA, Bradley K and Bickel JT: 1D5 and 6F11: an immunohistochemical comparison of two monoclonal antibodies for the evaluation of estrogen receptor status in primary breast carcinoma. Am J Clin Pathol. 123:276–280. 2005. View Article : Google Scholar
25.	Goulding H, Pinder S, Cannon P, et al: A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples. Hum Pathol. 26:291–294. 1995. View Article : Google Scholar : PubMed/NCBI
26.	Shousha S: Oestrogen receptor status of breast carcinoma: Allred/H score conversion table. Histopathology. 53:346–347. 2008. View Article : Google Scholar : PubMed/NCBI
27.	Sapino A, Cassoni P, Ferrero E, et al: Estrogen receptor alpha is a novel marker expressed by follicular dendritic cells in lymph nodes and tumor-associated lymphoid infiltrates. Am J Pathol. 163:1313–1320. 2003. View Article : Google Scholar
28.	Kim R, Kaneko M, Arihiro K, et al: Extranuclear expression of hormone receptors in primary breast cancer. Ann Oncol. 17:1213–1220. 2006. View Article : Google Scholar : PubMed/NCBI
29.	Kostopoulos S, Glotsos D, Cavouras D, et al: Computer-based association of the texture of expressed estrogen receptor nuclei with histologic grade using immunohistochemically-stained breast carcinomas. Anal Quant Cytol Histol. 31:187–196. 2009.
30.	Taylor CR and Levenson RM: Quantification of immunohistochemistry – issues concerning methods, utility and semiquantitative assessment II. Histopathology. 49:411–424. 2006.